Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$1.15B
-
Value change
-
+$38.2M
-
Put/Call ratio
-
1.08
-
Number of buys
-
115
-
Number of sells
-
-76
-
Price
-
$35.83
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2018
251 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q2 2018.
Editas Medicine, Inc. - Common Stock (EDIT) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 82.8M outstanding shares and own 38.83% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.59M shares), BlackRock Inc. (3.46M shares), FMR LLC (2.89M shares), STATE STREET CORP (2.6M shares), Capital World Investors (2.18M shares), ARK Investment Management LLC (2.18M shares), MORGAN STANLEY (2.07M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares), Viking Global Investors LP (931K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (784K shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.